Stock Events

Stock Events

Valiant 

CHF154.80
59
-CHF0.20-0.13% 14:15 Today

Statistics

Day High
154.8
Day Low
154.6
52W High
169
52W Low
145.4
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23OctExpected
Q1 2026
Next
0.01
0.01
0.02
0.02
Expected EPS
0.017127214985260802
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VATNE.SW. It's not an investment recommendation.
Swiss Re
26
SREN.SW
Nestle SA
20
NESN.SW
Novartis
20
NOVN.SW
Zurich Insurance Group
19
ZURN.SW

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical company that competes with Valiant in various therapeutic areas, including infectious diseases and oncology.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson operates in similar sectors as Valiant, offering a wide range of pharmaceutical products and competing in healthcare solutions.
Merck
MRK
Mkt Cap366B
Merck is a leading pharmaceutical company that competes with Valiant in developing medications for various diseases, including cancer and infectious diseases.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie competes with Valiant in the biopharmaceutical field, focusing on treatments for conditions such as rheumatoid arthritis and Crohn's disease.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that competes with Valiant in areas like oncology and neurology, offering innovative medicines.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline is a pharmaceutical and healthcare company that competes with Valiant in developing vaccines and medications for a variety of illnesses.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is a global biopharmaceutical company competing with Valiant in the discovery, development, and delivery of medicines for cancer and other diseases.
Sanofi
SNY
Mkt Cap107.39B
Sanofi is a global pharmaceutical company that competes with Valiant in providing healthcare solutions across a broad range of therapeutic areas.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes with Valiant in the pharmaceutical and diagnostics sectors, focusing on oncology, immunology, and infectious diseases.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Valiant in developing and commercializing prescription medicines in several therapeutic areas.

About

VALIANT HOLDING BERN
Show more...
CEO
Country
Switzerland
ISIN
CH1549892193

Listings

SW
CH
VATNE.SW
LSE
GB
0QPU.LSE
SW
CH
VATN.SW
STU
DE
VAT.STU

0 Comments

Share your thoughts

FAQ

What is Valiant stock price today?▼
The current price of VATNE.SW is CHF154.80 CHF — it has decreased by -0.13% in the past 24 hours. Watch Valiant stock price performance more closely on the chart.
What is Valiant stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on SIX Swiss Exchange exchange Valiant stocks are traded under the ticker VATNE.SW.
When is the next Valiant earnings date?▼
Valiant is going to release the next earnings report on October 23, 2026.
What were Valiant earnings last quarter?▼
VATNE.SW earnings for the last quarter are 0.01 CHF per share, whereas the estimation was N/A CHF resulting in a N/A surprise. The estimated earnings for the next quarter are N/A CHF per share.
In which sector is Valiant located?▼
Valiant operates in the Other sector.
When did Valiant complete a stock split?▼
Valiant has not had any recent stock splits.